• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AccuReg Acquires Digital Patient Engagement Technology Company

Share:

November 23, 2020

AccuReg, a healthcare technology solutions company offering a full suite of front-end revenue cycle management solutions for health systems and hospitals, has acquired Orlando-based Zenig, an innovator in patient engagement technology solutions that enable touchless check-in, virtual waiting rooms, patient flow and bi-directional communication methods.

This acquisition aligns with AccuReg’s strategy to build on its market-leading patient access suite and seamlessly integrate digital patient engagement with the revenue cycle to help health systems protect and grow net revenue as patients assume tasks traditionally handled by hospital staff.

“This acquisition is transformative for our company and, ultimately, the health systems we serve. By combining Zenig’s innovative digital patient engagement technology with AccuReg’s market-leading, front-end revenue cycle management solutions, we can provide health systems with solutions that give consumers an experience similar to shopping on Amazon while preventing denials, increasing pre-service revenue and reducing downstream costs,” said AccuReg CEO and Founder Paul Shorrosh. “Together, we will set the standard for seamless digital patient access and engagement that will strengthen health systems’ brands and attract more patients to their facilities.”

With the demand for digital patient engagement technology at an all-time high due to COVID-19 and looming price transparency deadlines, hospitals must deliver consumer-friendly digital patient access solutions that support both patient safety and consumerism. AccuReg has been at the forefront of price transparency solutions, offering health systems payment estimation and payment tools that deliver accurate out-of-pocket cost estimates to consumers. With the Zenig acquisition, AccuReg will offer fully automated digital patient access solutions that allow patients to engage online using digital messaging via their smartphones, tablets and computers, while enabling a singular patient experience when accessing care across health systems.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“AccuReg shares our mission of serving health systems with innovations that improve the patient experience while helping providers capture full reimbursement for their services,” said Zenig CEO Shawn Zimmerman. “Consumers want to engage with healthcare similarly to how they book travel with companies like Expedia or Travelocity. By joining AccuReg, we will provide patients with that experience and seamlessly integrate it with the revenue cycle to deliver a win-win.”

Zimmerman will join the AccuReg leadership team and all other Zenig employees will continue to serve customers from the company’s Orlando office.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • CONMED Completes Acquisition of Biorez, Inc.CONMED Completes Acquisition of Biorez, Inc.
  • BioSpace Global Roundup: UCB and Microsoft Pair AI and Drug Discovery TechnologyBioSpace Global Roundup: UCB and Microsoft Pair AI and Drug Discovery Technology
  • Why Hasn’t A More Holistic Approach to Patient Care Become The Norm?Why Hasn’t A More Holistic Approach to Patient Care Become The Norm?
  • Powered By Biofourmis, Blessing Health System Partners Launches Home Hospital ServicesPowered By Biofourmis, Blessing Health System Partners Launches Home Hospital Services
  • Trovagene Announces $5.0 Million Private Placement Priced At-the-MarketTrovagene Announces $5.0 Million Private Placement Priced At-the-Market
  • Paratek Pharmaceuticals Jumps Amid Report About Takeover Interest.Paratek Pharmaceuticals Jumps Amid Report About Takeover Interest.
  • Eisai buys out Purdue rights to end collaborationEisai buys out Purdue rights to end collaboration
  • Public seems to know value of clinical trials, but not how they workPublic seems to know value of clinical trials, but not how they work

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications